glp 1 drugs pregnancy Glucagon-like peptide-1 receptor agonist use in pregnancy: a review Can You Take GLP-1 Meds
Description
Despite a few potential ocular risks caused by GLP-1RAs, more clinical studies continue to discover and confirm their beneficial role in the eye, providing hope for creating a new weapon to treat eye diseases
Innate immunity in Alzheimers disease
Obesity in adults: a clinical practice guideline
Therefore, unless combined with insulin or sulfonylurea, tirzepatide does not increase the risk of hypoglycemia
doi: 10.1016/j.pharmthera.2020.107503
Among the most promising developments is Amycretin, a dual-acting GLP-1 and amylin receptor agonist developed by Novo Nordisk
